Chaurasia A, Singh N, D Sahu D, Mishra A. Comparative Evaluation of role of Lysyl oxidase gene (LOXG473A) expression in pathogenesis and malignant transformation of Oral Submucous Fibrosis. J Clin Exp Dent. 2019;11(10):e858-64.

 

doi:10.4317/jced.55980

https://doi.org/10.4317/jced.55980

 

____________________________________________________________________________________________________________________________________________________________________

 

References

1. Rajalalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis- a collagen metabolic disorder. J Oral Pathol Med. 2005;34:321-8.
https://doi.org/10.1111/j.1600-0714.2005.00325.x
PMid:15946178

 

2. Shieh TM, Tu HF, Chang KW, Liu CJ. Association between lysyl oxidase polymorphisms and oral submucous fibrosis in older male areca nut chewers. J oral Pathol Med. 2009;38:109-13.
https://doi.org/10.1111/j.1600-0714.2008.00695.x
PMid:18764858

 

3. Cox SC, Walker DM. Oral submucous fibrosis-A review. Aust Dent J. 1996;41:294-9.
https://doi.org/10.1111/j.1834-7819.1996.tb03136.x
PMid:8961601

 

4. Trivedy CR, Warnakualsuriya KA, Peters TJ, Senkus R, Hazarey VK, Jhonson KW. Raised tissue copper levels in Oral submucous fibrosis. J oral pathol Med. 2000;29:241-8.
https://doi.org/10.1034/j.1600-0714.2000.290601.x
PMid:10890553

 

5. Sheih TM, Lin SC, Lie CJ, Chang SS, KU TH, Chang KW. Association of expression abberances and genetic polymorphisms of lysyl oxidase with areca associated oral tumorogenesis. Clin Cancer Res. 2007;13:4378-85.
https://doi.org/10.1158/1078-0432.CCR-06-2685
PMid:17671119

 

6. Schache M, Baired PN . Assesment of the association of matrix metalloproteinases with myopia, refractive error and ocular biometric measures in an Australian cohort. PLos one. 2012;7:471-81.
https://doi.org/10.1371/journal.pone.0047181
PMid:23077567 PMCid:PMC3471969

 

7. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2006;42:561-8.
https://doi.org/10.1016/j.oraloncology.2005.08.005
PMid:16311067

 

8. Cox SC, Walker DM. Oral submucous fibrosis. A review. Aust Dent J. 1996;41:294-9.
https://doi.org/10.1111/j.1834-7819.1996.tb03136.x
PMid:8961601

 

9. Yang YH, Lee HY, Tung S, Shieh TY. Epidemiological survey of oral submucous fibrosis and leukoplakia in aborigines of Taiwan. J Oral Pathol Med. 2001;30:213-9.
https://doi.org/10.1034/j.1600-0714.2001.300404.x
PMid:11302240

 

10. Canniff JP, Harvey W, Harris M. Oral submucous fibrosis: its pathogenesis and management. Br Dent J. 1986;160:429-34.
https://doi.org/10.1038/sj.bdj.4805876
PMid:3459494

 

11. Seedat HA, van Wyk CW. Betel-nut chewing and sub- mucous fibrosis in Durban. S Afr Med J. 1988;74:568-71.

PMid:3194805

 

12. Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW. Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med. 1994;23:65-9.
https://doi.org/10.1111/j.1600-0714.1994.tb00258.x
PMid:8164155

 

13. Zain RB, Ikeda N, Razak IA, et al. A national epidemi- ological survey of oral mucosal lesions in Malaysia. Community Dent Oral Epidemiol. 1997;25:377-83.
https://doi.org/10.1111/j.1600-0528.1997.tb00959.x
PMid:9355776

 

14. Sinor PN, Gupta PC, Murti PR, et al. A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med. 1990;19:94-8.
https://doi.org/10.1111/j.1600-0714.1990.tb00804.x
PMid:2341977

 

15. Tang JG, Jian XF, Gao ML, Ling TY, Zhang KH. Epidemiological survey of oral submucous fibrosis in Xiangtan City, Hunan Province, China. Community Dent Oral Epidemiol. 1997;25:177-80.
https://doi.org/10.1111/j.1600-0528.1997.tb00918.x
PMid:9181294

 

16. Gupta PC, Hebert JR, Bhonsle RB, Sinor PN, Mehta H, Mehta FS. Dietary factors in oral leukoplakia and submucous fibrosis in a population-based case control study in Gujarat, India. Oral Dis. 1998;4:200-6.
https://doi.org/10.1111/j.1601-0825.1998.tb00279.x
PMid:9972171

 

17. Seedat HA, van WykCW. Submucous fibrosis (SF) in ex-betel nut chewers: a report of 14 cases. J Oral Pathol. 1988;17:226-9.
https://doi.org/10.1111/j.1600-0714.1988.tb01529.x

PMid:3144586

 

18. Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS. Increased tissue inhibitor of metalloproteinase-1 expres- sion and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol. 2002;38:195-200.
https://doi.org/10.1016/S1368-8375(01)00045-8

 

19. Shieh DH, Chiang LC, Shieh TY. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol. 2003;9:728-35.
https://doi.org/10.1016/S1368-8375(03)00101-5

PMid:12907213

 

20. Scutt A, Meghji S, Canniff JP, Harvey W. Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis. Experientia. 1987;43:391-3.
https://doi.org/10.1007/BF01940422
PMid:3032668

 

21. Tsai CH, Chou MY, Chang YC. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med. 2003;32:146-53.
https://doi.org/10.1034/j.1600-0714.2003.00004.x
PMid:12581384

 

22. Haque MF, Harris M, Meghji S, Barrett AW. Immuno- localization of cytokines and growth factors in oral submucous fibrosis. Cytokine. 1998;10:713-9.
https://doi.org/10.1006/cyto.1997.0342
PMid:9770333

 

23. Meghji S, Scutt A, Harvey W, Canniff JP. An in-vitro comparison of human fibroblasts from normal and oral submucous fibrosis tissue. Arch Oral Biol. 1987;32:213-5.
https://doi.org/10.1016/0003-9969(87)90138-5

PMid:3478024

 

24. Lin HJ, Lin JC. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function. Oral Dis. 2007;13:407-13.
https://doi.org/10.1111/j.1601-0825.2006.01313.x
PMid:17577328

 

25. Chiu CJ, Chang ML, Chiang CP, Hahn LJ, Hsieh LL, Chen CJ. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibro- sis. Cancer Epidemiol Biomarkers Prev. 2002;11:646-53.

PMid:12101112

 

26. Liu CJ, Lee YJ, Chang KW, Shih YN, Liu HF, Dang CW. Polymorphism of the MICA gene and risk for oral submucous fibrosis. J Oral Pathol Med. 2004;33:1-6.
https://doi.org/10.1111/j.1600-0714.2004.00047.x
PMid:14675133

 

27. Shin YN, Liu CJ, Chang KW, Lee YJ, Liu HF. Association of CTLA-4 gene polymorphism with oral submucous fibrosis in Taiwan. J Oral Pathol Med. 2004;33:200-3.
https://doi.org/10.1111/j.0904-2512.2004.00081.x
PMid:15061706

 

28. Tu HF, Liu CJ, Chang CS, et al. The functional (-1171 5A - >6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users. J Oral Pathol Med. 2006;35:99-103.
https://doi.org/10.1111/j.1600-0714.2006.00370.x
PMid:16430740

 

29. Tzong-Ming Shieh, His-Feng Tu , Ti-Hsuan Ku, Shu-Shin Chang, Kuo-Wei Chang, Chung-Ji Liu. Association between lysyl oxidase polymorphisms and oral submucous fibrosis in older male areca chewers. J Oral Pathol Med. 2009;38:109-113.
https://doi.org/10.1111/j.1600-0714.2008.00695.x
PMid:18764858

 

30. Shieh TM, Tu HF, Ku TH, Chang SS, Chang KW, Liu CJ. Association between lysyl oxidase polymorphisms and oral submucous fibrosis in older male areca chewers. J Oral Pathol Med. 2009;38:109-13.
https://doi.org/10.1111/j.1600-0714.2008.00695.x
PMid:18764858

 

31. Shieh TM, Lin SC, Liu CJ, Chang SS, Ku TH, Chang KW. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis. Clin Cancer Res. 2007;13:4378-85.
https://doi.org/10.1158/1078-0432.CCR-06-2685
PMid:17671119

 

32. Rucker RB, Kosonen T, Clegg MS, Mitchell AE, Rucker BR, Uriu-Hare JY, et al. Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am J Clin Nutr. 1998;67:996-1002.
https://doi.org/10.1093/ajcn/67.5.996S
PMid:9587142

 

33. Trivedy CR, Warnakualsuriya S, Peters TJ, Senkus R, Hazarey VK, Johnson NW. Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med. 2000;29:241-8.
https://doi.org/10.1034/j.1600-0714.2000.290601.x
PMid:10890553

 

34. Sommer P1, Gleyzal CRaccurt MDelbourg MSerrar MJoazeiro P, et al.Transient expression of lysyl oxidase by liver myofibroblasts in murine schistosomiasis. Lab Invest. 1993;69:460-70.

PMid:7901452

 

35. Shanley CJ, Mehrnaz GK, Sarkar R. Transforming growth factor-b-1 increases lysyl oxidase activity and mRNA in rat aortic smooth muscle cells. J Vasc Surg. 1997;25.
https://doi.org/10.1016/S0741-5214(97)70254-4

 

36. Haque MF, Meghji S, Harris M. Immuno-histochemistry of oral submucous fibrosis: pre- and post-interferon gamma treatment. Oral Dis. 1997;3:289-91.

 

37. Rucker RBRomero-Chapman NWong TLee JSteinberg FMMcGee C, et al. Modulation of lysyl oxidase by dietary copper in rats. J Nutr. 1996;126:51-60.
https://doi.org/10.1093/jn/126.1.51
PMid:8558325

 

38. Rucker RB, Kosonen T, Clegg MS. Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am J Clin Nutr. 1998;67:996S-1002S.
https://doi.org/10.1093/ajcn/67.5.996S
PMid:9587142

 

39. Werman MJ, Bhathena SJ, Turnlund JR. Dietary copper intake influences skin lysyl oxidase in young men. Agricultural Research Service Report 70494.Baltimore: Tektran, 1997; 13.
https://doi.org/10.1016/S0955-2863(97)00004-1